• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - CW; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - CW; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMC4242C200TU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Fever (1858); Hemorrhage/Bleeding (1888); Rash (2033); Swelling (2091); Electrolyte Imbalance (2196); Constipation (3274)
Event Date 10/25/2018
Event Type  Injury  
Manufacturer Narrative
Other relevant device(s) are: product id: v amc4242c200tu, serial/lot #: (b)(4), ubd: 27-may-2020, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
A valiant stent graft system was implanted in the patient for the endovascular treatment of a fusiform descending thoracic aneurysm.It was noted a non-mdt stent graft (gelweave) was previously implanted in the ascending aorta approximately 2 months previously.It was reported from one post the index procedure to approximately 2 weeks post the index procedure the patient experienced the following symptoms: thrombocytopenia resolving without treatment abdominal pain unresolved without treatment elevated liver enzymes recovering without treatment.Anemia with drop in hb unresolved and continuing with treatment hypokalemia resolved with treatment constipation resolved with treatment maculopapular rash by right neck area related to surgical tape dressing used for central line access resolved with treatment.Postoperative fever with symptoms of hypovolemic hyponatremia, lactic acidosis¿ related to the post implantation syndrome.This was successfully treated and confirmed as resolved.Occult gastrointestinal bleeding treated however unresolved and continuing with treatment left arm swelling with mild edema around the incision site (procedure access) resolved with treatment.All of the reported events were assessed as related to the index procedure.No additional clinical sequelae were reported and the patient will be monitored.
 
Manufacturer Narrative
Additional information received: the valiant captivia stent grafts implanted during the index procedure were placed in zones 3, 4 and 5.The previously reported abdominal pain was reported as likely due to the anesthesia and acute surgery.A ct was carried out 3 months post the index procedure showed no blood loss.The patient recovered without treatment.The previously reported anemia was treated with medication but is still unresolved.All previously reported events were assessed as related to the index procedure by both the investigator and the sponsor.The patient also experienced hypomagnesemia 3 months post the index procedure which was assessed as related to the study procedure by the investigator and the sponsor, and recovered without treatment.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - CW
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
091708096
MDR Report Key8119301
MDR Text Key128869718
Report Number2953200-2018-01643
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00643169346734
UDI-Public00643169346734
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2020
Device Model NumberVAMC4242C200TU
Device Catalogue NumberVAMC4242C200TU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/03/2018
Initial Date FDA Received11/30/2018
Supplement Dates Manufacturer Received12/13/2018
02/20/2019
Supplement Dates FDA Received01/07/2019
03/11/2019
Date Device Manufactured02/28/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age61 YR
Patient Weight52
-
-